Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy TA1126 28 January 2026 28 January 2026 Concizumab for treating ...
News about Donald Trump, the 45th and 47th US president, including comment and features from the Guardian Highly sensitive communique has roiled Washington over the past week – key US politics stories ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results